News
Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
IREN Limited (NASDAQ: IREN) (together with its subsidiaries, 'IREN” or 'the Company”), today published its monthly update for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback